HOME Top Market Reports In-Situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

In-Situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

By: marketsandmarkets.com
Publishing Date: August 2015
Report Code: BT 3649

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


In-situ hybridization has applications across varied industry verticals, such as cancer diagnostics, immunology, neurosciences, and cytology. Cancer diagnostics is anticipated to be the leading application segment of the in-situ hybridization market.

The global market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, rising number of initiatives undertaken by the government, such as create awareness about cancer disease and providing funding to support related researches.

The global in-situ hybridization market is estimated at $554.4 Million 2014 and is projected to reach $681.0 Million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market has been segmented on the basis of four categories, namely, type, application, end user, and geography. The application segment is subdivided into cancer diagnostics, immunology, neurosciences, cytology, and others. Among applications, the cancer diagnostics segment accounted for the largest share in the global market in 2014, and accounted for a market share of 56.7%. It is estimated to grow at the highest CAGR of 4.7% from 2014 to 2019, due to the increased application of the in-situ hybridization techniques in the diagnosis of cancer.

The market on the basis of geography has been classified into four regions, namely North America, Europe, and Asia-Pacific. North America contributed the largest share to the global market, and the market in the region was valued at $221.8 Million in 2014. It is expected to grow at a CAGR of 4.0% during the given forecast period.

The major players operational in the global in-situ hybridization market are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnership, among others to achieve growth in the global market.

Scope of the Report:

This report categorizes the global market on the basis of type, application, end-user and geography.

Market Segmentation, by Type:

The in-situ hybridization market has been segmented on the basis of type into DNA in-situ hybridization and RNA in-situ hybridization.

Market Segmentation, by Application:

The in-situ hybridization market has been segmented on the basis of application into cancer diagnostics, immunology, neurosciences, cytology, and others.

Market Segmentation, by End-User:

The in-situ hybridization market has been segmented on the basis of end-user into hospitals, pharma & biotech companies, research labs, and CROs.

Market Segmentation, by Geography:

The geographic analysis covers North America, Europe, and Asia-Pacific.

Table of Contents

1 Introduction

2 Executive Summary

3 Market Overview

4 Market Dynamics

5 In-Situ Hybridization Market, By Type

6 In-Situ Hybridization Market, By Application

7 In-Situ Hybridization Market, By End User

8 In-Situ Hybridization Market, By Geography

9 Competitive Landscape

10 Company Profiles
     10.1 Abbott
     10.2 Biogenex
     10.3 Biosb 
     10.4 F. Hoffmann-La Roche Ltd
     10.5 Sigma-Aldrich Co. Llc. 
     10.6 Advanced Cell Diagnostics 
     10.7 Affymetrix, Inc.
     10.8 Exiqon A/S
     10.9 Agilent Technologies
     10.10 Thermo Fisher Scientific, Inc.

11 Appendix


List of Tables (40 Tables)

Table 1 In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 2 DNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 3 DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 4 DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 5 RNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 6 RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012-2019 (USD MN)
Table 7 RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012-2019 (USD MN)
Table 8 In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
Table 9 Cancer Diagnostics Market, By Geography, 2012-2019 (USD MN)
Table 10 Cytology Market, By Geography, 2012-2019 (USD MN)
Table 11 Neuroscience Market, By Geography, 2012-2019 (USD MN)
Table 12 Immunology Market, By Geography, 2012-2019 (USD MN)
Table 13 Other Applications Market, By Geography, 2012-2019 (USD MN)
Table 14 Market, By End User, 2012 - 2019 (USD MN)
Table 15 Hospital Market, By Geography, 2012-2019 (USD MN)
Table 16 Pharma & Biotech Companies Market, By Geography, 2012-2019 (USD MN)
Table 17 Research Labs Market, By Geography, 2012-2019 (USD MN)
Table 18 Cros Market, By Geography, 2012-2019 (USD MN)
Table 19 Other End User Market, By Geography, 2012-2019 (USD MN)
Table 20 In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 21 North America In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 22 North America DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 23 North America RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 24 North America In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
Table 25 North America In-Situ Hybridization Market, By End User, 2012-2019 (USD MN)
Table 26 Europe In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 27 Europe DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 28 Europe RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 29 Europe: Market, By Application, 2012-2019 (USD MN)
Table 30 Europe: Market, By End User, 2012- 2019 (USD MN)
Table 31 APAC: Market, By Type, 2012- 2019 (USD MN)
Table 32 APAC DNA In-Situ Hybridization Market, By Technique, 2012- 2019 (USD MN)
Table 33 APAC RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 34 APAC: Market, By Application, 2012-2019 (USD MN)
Table 35 APAC: Market, By End User, 2012-2019 (USD MN)
Table 36 RoW: Market, By Type, 2012- 2019 (USD MN)
Table 37 RoW DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 38 RoW RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 39 RoW: Market, By Application, 2012-2019 (USD MN)
Table 40 RoW: Market, By End User, 2012- 2019 (USD MN)


List of Figures (35 Figures)

Figures 1 Market Size, 2014 & 2019
Figures 2 Market Size, 2014 & 2019
Figures 3 Market Size, 2014 & 2019
Figures 4 Market Size, 2014 & 2019 (USD MN)
Figures 5 Market, By Type, 2014 & 2019 (USD MN)
Figures 6 DNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
Figures 7 RNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
Figures 8  Market, By Application, 2014 & 2019 (USD MN)
Figures 9 Market, By End-User, 2014 & 2019 (USD MN)
Figures 10 In-Situ Hybridization Market, By Type,  2014 & 2019 (USD MN)
Figures 11 DNA In-Situ Hybridization Market, By Geography,  2012 - 2019 (USD MN)
Figures 12 DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 13 DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 14 RNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 15 RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012 - 2019 (USD MN)
Figures 16 RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012 - 2019 (USD MN)
Figures 17 Market, By Application, 2014 & 2019 (USD MN)
Figures 18 Market, By Application, 2014 & 2019 (USD MN)
Figures 19 Cancer Diagnostics Market, By Geography, 2012 - 2019 (USD MN)
Figures 20 Cytology Market, By Geography, 2012 - 2019 (USD MN)
Figures 21 Neuroscience Market, By Geography, 2012 - 2019 (USD MN)
Figures 22 Immunology Market, By Geography, 2012 - 2019 (USD MN)
Figures 23 Other Application Market, By Geography, 2012 - 2019 (USD MN)
Figures 24 Market, By End User, 2012 - 2019 (USD MN)
Figures 25 End-User Market, By Geography, 2014 & 2019 (USD MN)
Figures 26 Hospitals Market, By Geography, 2012 - 2019 (USD MN)
Figures 27 Pharma & Biotech Companies Market, By Geography, 2012 - 2019 (USD MN)
Figures 28 Research Labs  Market, By Geography, 2012 - 2019 (USD MN)
Figures 29 Cros  Market, By Geography, 2012 - 2019 (USD MN)
Figures 30 Others  Market, By Geography, 2012 - 2019 (USD MN)
Figures 31 In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 32 North America: Market, 2014 & 2019 (%)
Figures 33 Europe: Market, 2014 & 2019 (%)
Figures 34 APAC: Market, 2014 & 2019 (%)
Figures 35 RoW: Market, 2014 & 2019 (%)

This report on the global in-situ hybridization market has been segmented based on type, application, end user, and geography. It analyzes competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global market and analyses the market with explicit focus on high-growth applications and the fastest-growing market segments. The major drivers for the growth of this market are the increasing prevalence of cancer and growing usage of personalized medicines for its treatment. Furthermore, the rising number of initiatives undertaken by the government, such as creating awareness about cancer disease and providing funds to support related researches are some of the important factors fueling the growth of this market.

The global in-situ hybridization market is estimated at $554.4 Million 2014 and is projected to reach $681.0 Million by 2019, at a CAGR of 4.2% from 2014 to 2019.

This report profiles the major companies operational in the global market, which are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).

On the basis of type, the market has been classified into DNA in-situ hybridization and RNA in-situ hybridization. DNA in-situ hybridization technique led the global market in 2014 and accounted for a market share of 75.4%. This segment is estimated to grow at a CAGR of 4.2% from 2014 to 2019. The DNA and RNA in-situ hybridizations can further be divided into fluorescent in-situ hybridization (FISH) and chromogenic in-situ hybridization (CISH). Amongst these, DNA fluorescent in-situ hybridization (FISH) segment accounted for the largest share of 55.7% in the global market in 2014. It is estimated to grow at a CAGR of 4.0% during the forecast period.

Based on end users, the market has been classified into hospitals, pharma & biotech companies, research labs, and contract research organizations (CROs), where hospital segment accounted for the largest share of 49.6% in the global market in 2014, and is estimated to grow at a CAGR of 4.5% during the forecast period.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and RoW. The in-situ hybridization market in North America contributed the largest share to the global market. The markets in the European and Asia-Pacific regions are expected to grow at CAGRs of 4.3% and 4.7% respectively from 2014 to 2019.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo